Trial Profile

An Adaptive Phase I Intra-patient Dose Escalation Study of Fenretinide in Adult Cystic Fibrosis Patients

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fenretinide (Primary)
Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
Focus Adverse reactions

Most Recent Events

18 May 2016 Results of subgroup analysis presented at the 112th International Conference of the American Thoracic Society
17 Mar 2016 Status changed from active, no longer recruiting to completed, according to a Laurent Pharmaceuticals media release.
15 Jun 2015 Topline results published in the Laurent Pharmaceuticals Media Release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com